Genmab stock heads into the open after a 0.84 percent gain
Published on 09/24/2026 at 06:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Genmab stock closed at DKK 2,279.00 on Nasdaq Copenhagen on September 23, 2026, up 0.84 percent. The US-listed ADR closed at USD 35.22 on the same date, while the Nasdaq Composite fell 1.13 percent to 26,936.04.
September 23, 2026 in numbers
Genmab A/S (ISIN DK0010272202) traded between DKK 2,258.00 and DKK 2,207.00 on Nasdaq Copenhagen and recorded volume of 101,053 shares. The closing price was DKK 19.00, or 0.84 percent, above the previous close of DKK 2,260.00.
The US ADR reached USD 35.66 during the September 23, 2026 session and closed at USD 35.22, compared with a previous close of USD 35.22 in the MarketBeat report. The Copenhagen share price also reflected a same-session increase of 13.81 percent over five trading days in the MarketScreener snapshot.
Scheduled data for September 24, 2026
US initial jobless claims, August building permits and August new home sales are scheduled for release on September 24, 2026, according to SVMUU. The scheduled releases may affect broader equity and biotechnology sentiment through their effect on interest-rate expectations.
